EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Developing T Cell Epitope-Based Vaccines Against Infection: Challenging but Worthwhile

Xian Tang iD, Wei Zhang, Zheng Zhang

Vaccines · 28.01.2025 · 13 (2) · 135

DOI: 10.3390/vaccines13020135 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Vaccines, online erschienen am 28.01.2025. Verfasst von Xian Tang und 2 weiteren Autor:innen. Beteiligte Einrichtung: The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Institute for Hepatology, National Clinical Resear…. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 189 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Science Fund for Distinguished Young Scholars, Chinese Academy of Medical Sciences Clinical and Translational Medicine Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

T cell epitope-based vaccines are designed to elicit long-lived pathogen-specific memory T cells that can quickly activate protective effector functions in response to subsequent infections. These vaccines have the potential to provide sustained protection against mutated variants, such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which are increasingly capable of evading neutralizing antibodies. Recent advancements in epitope discovery, T cell receptor analysis, and bioinformatics have enabled the precise selection of epitopes and the sophisticated design of epitope-based vaccines. This review outlines the development process for T cell epitope-based vaccines. We summarize the current progress in T cell epitope discovery technologies, highlighting the advantages and disadvantages of each method. We also examine advancements in the design and optimization of epitope-based vaccines, particularly through bioinformatics tools. Additionally, we discuss the challenges of validating the accurate processing and presentation of individual epitopes and establishing suitable rodent models to evaluate vaccine immunogenicity and protective efficacy.

Schlagwörter

Stichwörter der Autor:innen

T cell epitopeinfectionvaccine development

Autor:innen und Institutionen

  • The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Sh…
  • Guangdong Key Laboratory for Anti-Infection Drug Quality Evaluation, Shenzhen 518112, China.

ORCID-Profile: Xian Tang

Förderung

  • National Key R&D Program of China
  • National Science Fund for Distinguished Young Scholars
  • Chinese Academy of Medical Sciences Clinical and Translational Medicine Research Project
  • Shenzhen Science and Technology Programs

Zitieren

APA

Tang, X., Zhang, W., & Zhang, Z. (2025). Developing T Cell Epitope-Based Vaccines Against Infection: Challenging but Worthwhile. Vaccines, 13(2), 135. https://doi.org/10.3390/vaccines13020135

Vancouver

Tang X, Zhang W, Zhang Z. Developing T Cell Epitope-Based Vaccines Against Infection: Challenging but Worthwhile. Vaccines. 2025;13(2):135. doi:10.3390/vaccines13020135

BibTeX
@article{Tang2025,
  author = {Tang, Xian and Zhang, Wei and Zhang, Zheng},
  title = {Developing T Cell Epitope-Based Vaccines Against Infection: Challenging but Worthwhile},
  journal = {Vaccines},
  year = {2025},
  volume = {13},
  number = {2},
  pages = {135},
  doi = {10.3390/vaccines13020135}
}
Kostenlos starten →